Lymphocytic hypereosinophilic syndrome (Q107461): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed label, description and/or aliases in pt-br, en |
Changed an Item |
||
| Property / Canonical URI | |||
| Property / Canonical URI: https://id.who.int/icd/entity/367714724 / rank | |||
Normal rank | |||
Revision as of 14:27, 17 August 2026
Lymphocytic hypereosinophilic syndrome is a subtype of Hypereosinophilic Syndrome with the presence of a monoclonal T cell population detected in conjunction with immunophenotypically aberrant T cell populations. Manifestations are mostly cutaneous (eczematous dermatitis, nodules, papules, plaques, urticaria and -or angioedema with erythroderma), as well as gastrointestinal, rheumatological symptoms, thromboembolism and lymphadenopathy. A subset develop T cell lymphoma.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_367714724 |
||
| English | Lymphocytic hypereosinophilic syndrome |
Lymphocytic hypereosinophilic syndrome is a subtype of Hypereosinophilic Syndrome with the presence of a monoclonal T cell population detected in conjunction with immunophenotypically aberrant T cell populations. Manifestations are mostly cutaneous (eczematous dermatitis, nodules, papules, plaques, urticaria and -or angioedema with erythroderma), as well as gastrointestinal, rheumatological symptoms, thromboembolism and lymphadenopathy. A subset develop T cell lymphoma. |
